IE53696B1 - Solid shaped articles - Google Patents
Solid shaped articlesInfo
- Publication number
- IE53696B1 IE53696B1 IE2663/82A IE266382A IE53696B1 IE 53696 B1 IE53696 B1 IE 53696B1 IE 2663/82 A IE2663/82 A IE 2663/82A IE 266382 A IE266382 A IE 266382A IE 53696 B1 IE53696 B1 IE 53696B1
- Authority
- IE
- Ireland
- Prior art keywords
- composition
- mould
- chemical
- solid shaped
- shaped article
- Prior art date
Links
- 239000007787 solid Substances 0.000 title claims abstract description 16
- 239000000203 mixture Substances 0.000 claims abstract description 50
- 239000000126 substance Substances 0.000 claims abstract description 27
- 239000012876 carrier material Substances 0.000 claims abstract description 17
- 239000002904 solvent Substances 0.000 claims abstract description 14
- 239000002552 dosage form Substances 0.000 claims abstract description 11
- 238000007710 freezing Methods 0.000 claims abstract description 8
- 230000008014 freezing Effects 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims description 22
- 108010010803 Gelatin Proteins 0.000 claims description 17
- 229920000159 gelatin Polymers 0.000 claims description 17
- 239000008273 gelatin Substances 0.000 claims description 17
- 235000019322 gelatine Nutrition 0.000 claims description 17
- 235000011852 gelatine desserts Nutrition 0.000 claims description 17
- 239000000463 material Substances 0.000 claims description 7
- 239000003814 drug Substances 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 238000000859 sublimation Methods 0.000 abstract description 3
- 230000008022 sublimation Effects 0.000 abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 6
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 6
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 5
- 229930195725 Mannitol Natural products 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 239000000594 mannitol Substances 0.000 description 5
- 235000010355 mannitol Nutrition 0.000 description 5
- 229920000053 polysorbate 80 Polymers 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 229960004535 oxazepam Drugs 0.000 description 4
- ADIMAYPTOBDMTL-UHFFFAOYSA-N oxazepam Chemical compound C12=CC(Cl)=CC=C2NC(=O)C(O)N=C1C1=CC=CC=C1 ADIMAYPTOBDMTL-UHFFFAOYSA-N 0.000 description 4
- 229920000915 polyvinyl chloride Polymers 0.000 description 4
- 239000004800 polyvinyl chloride Substances 0.000 description 4
- 239000003617 indole-3-acetic acid Substances 0.000 description 3
- 230000005499 meniscus Effects 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 239000007952 growth promoter Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- JTEDVYBZBROSJT-UHFFFAOYSA-N indole-3-butyric acid Chemical compound C1=CC=C2C(CCCC(=O)O)=CNC2=C1 JTEDVYBZBROSJT-UHFFFAOYSA-N 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- DIWRORZWFLOCLC-HNNXBMFYSA-N (3s)-7-chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-1,4-benzodiazepin-2-one Chemical compound N([C@H](C(NC1=CC=C(Cl)C=C11)=O)O)=C1C1=CC=CC=C1Cl DIWRORZWFLOCLC-HNNXBMFYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- 241000220479 Acacia Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 1
- SEQDDYPDSLOBDC-UHFFFAOYSA-N Temazepam Chemical compound N=1C(O)C(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 SEQDDYPDSLOBDC-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000005030 aluminium foil Substances 0.000 description 1
- 229960003515 bendroflumethiazide Drugs 0.000 description 1
- HDWIHXWEUNVBIY-UHFFFAOYSA-N bendroflumethiazidum Chemical compound C1=C(C(F)(F)F)C(S(=O)(=O)N)=CC(S(N2)(=O)=O)=C1NC2CC1=CC=CC=C1 HDWIHXWEUNVBIY-UHFFFAOYSA-N 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- -1 colouring Substances 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 229940019862 cyclopenthiazide 0.5 mg Drugs 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 229960003883 furosemide Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229960004391 lorazepam Drugs 0.000 description 1
- 229940033312 lormetazepam 1 mg Drugs 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229940127234 oral contraceptive Drugs 0.000 description 1
- 239000003539 oral contraceptive agent Substances 0.000 description 1
- 229940095438 oxazepam 30 mg Drugs 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000005033 polyvinylidene chloride Substances 0.000 description 1
- 229920006316 polyvinylpyrrolidine Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 229960002153 prochlorperazine maleate Drugs 0.000 description 1
- DSKIOWHQLUWFLG-SPIKMXEPSA-N prochlorperazine maleate Chemical compound [H+].[H+].[H+].[H+].[O-]C(=O)\C=C/C([O-])=O.[O-]C(=O)\C=C/C([O-])=O.C1CN(C)CCN1CCCN1C2=CC(Cl)=CC=C2SC2=CC=CC=C21 DSKIOWHQLUWFLG-SPIKMXEPSA-N 0.000 description 1
- 238000009790 rate-determining step (RDS) Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960003188 temazepam Drugs 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000003856 thermoforming Methods 0.000 description 1
- 239000012815 thermoplastic material Substances 0.000 description 1
- 229920011532 unplasticized polyvinyl chloride Polymers 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F26—DRYING
- F26B—DRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
- F26B5/00—Drying solid materials or objects by processes not involving the application of heat
- F26B5/04—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum
- F26B5/06—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum the process involving freezing
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/34—Shaped forms, e.g. sheets, not provided for in any other sub-group of this main group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Agronomy & Crop Science (AREA)
- Dentistry (AREA)
- Physiology (AREA)
- Mechanical Engineering (AREA)
- General Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Environmental Sciences (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Jellies, Jams, And Syrups (AREA)
- Seasonings (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Materials For Medical Uses (AREA)
- Glass Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8136360 | 1981-12-02 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE822663L IE822663L (en) | 1983-06-02 |
| IE53696B1 true IE53696B1 (en) | 1989-01-18 |
Family
ID=10526336
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE2663/82A IE53696B1 (en) | 1981-12-02 | 1982-11-08 | Solid shaped articles |
Country Status (41)
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4950689A (en) * | 1987-03-31 | 1990-08-21 | Yang Robert K | Pectin delivery system |
| US5206025A (en) * | 1989-05-24 | 1993-04-27 | Rhone-Poulenc Sante | Porous pharmaceutical form and its preparation |
| US4946684A (en) * | 1989-06-20 | 1990-08-07 | American Home Products Corporation | Fast dissolving dosage forms |
| US5215756A (en) * | 1989-12-22 | 1993-06-01 | Gole Dilip J | Preparation of pharmaceutical and other matrix systems by solid-state dissolution |
| WO1993012770A1 (en) * | 1991-12-20 | 1993-07-08 | Pfizer Inc. | Porous shaped delivery devices and method of producing thereof |
| DE59309678D1 (de) * | 1992-01-17 | 1999-08-05 | Alfatec Pharma Gmbh | Verfahren zur Herstellung von Wirkstoff enthaltenden Pulvern, Granulaten oder Pellets mit einem Gerüst aus hydrophilen Makromolekülen und ihre Verwendung |
| US5876754A (en) * | 1992-01-17 | 1999-03-02 | Alfatec-Pharma Gmbh | Solid bodies containing active substances and a structure consisting of hydrophilic macromolecules, plus a method of producing such bodies |
| US5298261A (en) * | 1992-04-20 | 1994-03-29 | Oregon Freeze Dry, Inc. | Rapidly distintegrating tablet |
| US5271874A (en) * | 1992-11-04 | 1993-12-21 | Wesley-Jessen Corporation | Method for molding a hydrophilic contact lens |
| US5631023A (en) * | 1993-07-09 | 1997-05-20 | R.P. Scherer Corporation | Method for making freeze dried drug dosage forms |
| US5837287A (en) * | 1994-10-28 | 1998-11-17 | R P Scherer Corporation | Process for preparing solid pharmaceutical dosage forms |
| US5738875A (en) * | 1994-10-28 | 1998-04-14 | R.P. Scherer Corporation | Process for preparing solid pharmaceutical dosage forms |
| US20010021722A1 (en) * | 1995-03-02 | 2001-09-13 | Mary Brewer Francesca | Pharmaceutical compositions comprising monoamine oxidase b inhibitors |
| EG23659A (en) | 1995-03-24 | 2007-03-26 | Lilly Co Eli | Process and crystal forms of methyl-thieno-benzodiazepine |
| CN1191824C (zh) * | 1996-06-17 | 2005-03-09 | 詹森药业有限公司 | 双面凸的迅速崩解剂型 |
| US7255877B2 (en) * | 1996-08-22 | 2007-08-14 | Jagotec Ag | Fenofibrate microparticles |
| US6465016B2 (en) | 1996-08-22 | 2002-10-15 | Research Triangle Pharmaceuticals | Cyclosporiine particles |
| US6066092A (en) * | 1997-11-06 | 2000-05-23 | Cady; Roger K. | Preemptive prophylaxis of migraine device and method |
| US7189753B1 (en) | 1997-11-06 | 2007-03-13 | Cady Roger K | Preemptive prophylaxis of migraine |
| US6979456B1 (en) | 1998-04-01 | 2005-12-27 | Jagotec Ag | Anticancer compositions |
| CA2333648C (en) | 1998-05-29 | 2008-10-21 | Rtp Pharma Inc. | Thermoprotected microparticle compositions and process for terminal steam sterilization thereof |
| BR9915738A (pt) | 1998-11-20 | 2001-10-02 | Rtp Pharma Inc | Micropartìculas estabilizadas em fosfolipìdeos dispersìveis |
| JP4848572B2 (ja) * | 1999-05-07 | 2011-12-28 | 井関農機株式会社 | 乗用型作業車 |
| IL148685A0 (en) * | 1999-09-21 | 2002-09-12 | Rtp Pharma Inc | Surface modified particulate compositions of biologically active substances |
| JP2005508888A (ja) * | 2001-08-14 | 2005-04-07 | バイオティ セラピーズ コーポレイション | アルコール依存症またはアルコール中毒を治療する方法 |
| JP4042394B2 (ja) * | 2001-12-04 | 2008-02-06 | 味の素株式会社 | ブロック状凍結乾燥食品類の製造法 |
| ES2529568T3 (es) * | 2002-10-16 | 2015-02-23 | Medskin Solutions Dr. Suwelack Ag | Uso de cuerpos moldeados para aplicación externa |
| US20040234579A1 (en) * | 2003-05-22 | 2004-11-25 | Mark D. Finke, Inc. | Dietary supplements and methods of preparing and administering dietary supplements |
| EP2322198A2 (en) | 2003-11-10 | 2011-05-18 | Reprise Biopharmaceutics, LLC | Pharmaceutical compositions including low dosages of desmopressin |
| DE20321887U1 (de) | 2003-11-10 | 2012-01-20 | Allergan, Inc. | Arzneimittel umfassend niedrige Dosierungen von Desmopressin |
| US20100272762A1 (en) | 2009-04-22 | 2010-10-28 | Dr. Suwelack Skin & Health Care Ag | Freeze-Dried Coated Molded Article |
| EP2243469B1 (de) | 2009-04-22 | 2012-06-27 | Dr. Suwelack Skin & Health Care AG | Gefriergetrockneter Formkörper enthaltend Magnesiumascorbylphosphat |
| WO2011154866A1 (en) * | 2010-05-31 | 2011-12-15 | Haremlik Gida, Dekorasyon Ve Ekipmanlari Ticaret Sanayi Limited Sirketi | Capsule for pouring a powder in a device |
| CA3053189A1 (en) | 2012-12-20 | 2014-06-26 | Kashiv Biosciences, Llc | Orally disintegrating tablet formulation for enhanced bioavailability |
| US9901545B1 (en) | 2017-04-13 | 2018-02-27 | Richard C. Fuisz | Method and composition for making an oral soluble film, containing at least one active agent |
| US10238600B2 (en) | 2017-04-13 | 2019-03-26 | Richard C. Fuisz | Package, system and methods for custody and control of drugs, and method and composition for making an oral soluble film, containing at least one active agent |
| US10988638B2 (en) | 2018-03-08 | 2021-04-27 | Catalent U.K. Swindon Zydis Limited | Process to reduce endotoxin in gelatin |
| KR20210024549A (ko) * | 2018-06-29 | 2021-03-05 | 우니베르지타이트 겐트 | 제품 용량 단위의 동결, 건조 및/또는 동결 건조 |
| HUE064287T2 (hu) | 2019-02-22 | 2024-02-28 | Catalent Uk Swindon Zydis Ltd | Hatóanyagrészecske-bevonóanyag agglomerálódásának minimalizálása tárolás során, gyógyszerészeti termékek szétesési idejének stabilizálására |
| SG11202108659XA (en) | 2019-02-22 | 2021-09-29 | Catalent Uk Swindon Zydis Ltd | Minimizing aeration of suspensions during in-line mixing |
| SG11202109104XA (en) | 2019-02-22 | 2021-09-29 | Catalent Uk Swindon Zydis Ltd | Preserving functionally-coated api particles produced by solventless mixing processes in aqueous suspension |
| ES2966816T3 (es) | 2019-02-22 | 2024-04-24 | Catalent Uk Swindon Zydis Ltd | Minimización de la aglomeración, aireación y conservación del recubrimiento de composiciones farmacéuticas que comprenden ibuprofeno |
| AU2020330527A1 (en) * | 2019-08-12 | 2022-02-24 | Tenshi Kaizen Private Limited | Cannabidiol orally disintegrating tablets |
| WO2022178279A1 (en) | 2021-02-19 | 2022-08-25 | Nova Thin Film Pharmaceuticals Llc | Method and system for manufacturing oral soluble films, compositions of oral soluble films, oral soluble films made by thereby, and methods of use thereof |
| US11173114B1 (en) | 2020-07-10 | 2021-11-16 | Nova Thin Film Pharmaceuticals Llc | Method and system for manufacturing and oral soluble films and oral soluble films made by thereby |
| BR112023001716A2 (pt) | 2020-07-31 | 2023-04-04 | Catalent Uk Swindon Zydis Ltd | Composições farmacêuticas compreendendo api revestido |
| JP7689182B2 (ja) * | 2021-06-02 | 2025-06-05 | イビデン株式会社 | 粉末状植物賦活剤 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1206033A (en) * | 1967-01-24 | 1970-09-23 | Grace W R & Co | Improvements in or relating to methods of processing food |
| GB1548022A (en) * | 1976-10-06 | 1979-07-04 | Wyeth John & Brother Ltd | Pharmaceutial dosage forms |
| IE45770B1 (en) * | 1976-10-06 | 1982-11-17 | Wyeth John & Brother Ltd | Pharmaceutical dosage forms |
| CA1097233A (en) * | 1977-07-20 | 1981-03-10 | George K. E. Gregory | Packages |
-
1982
- 1982-11-08 IE IE2663/82A patent/IE53696B1/en not_active IP Right Cessation
- 1982-11-10 CA CA000415339A patent/CA1200960A/en not_active Expired
- 1982-11-11 GB GB08232189A patent/GB2119246B/en not_active Expired
- 1982-11-11 CY CY1326A patent/CY1326A/en unknown
- 1982-11-11 GR GR69796A patent/GR77773B/el unknown
- 1982-11-12 IN IN1325/CAL/82A patent/IN157896B/en unknown
- 1982-11-12 NZ NZ202482A patent/NZ202482A/en unknown
- 1982-11-15 DE DE8282306067T patent/DE3276260D1/de not_active Expired
- 1982-11-15 IL IL67266A patent/IL67266A/xx not_active IP Right Cessation
- 1982-11-15 EP EP82306067A patent/EP0081912B1/en not_active Expired
- 1982-11-15 AT AT82306067T patent/ATE27058T1/de not_active IP Right Cessation
- 1982-11-15 AR AR291296A patent/AR229543A1/es active
- 1982-11-15 ZA ZA828371A patent/ZA828371B/xx unknown
- 1982-11-16 AU AU90618/82A patent/AU554816B2/en not_active Expired
- 1982-11-19 FI FI823983A patent/FI77155C/fi not_active IP Right Cessation
- 1982-11-22 PH PH28170A patent/PH18441A/en unknown
- 1982-11-24 DZ DZ826716A patent/DZ481A1/fr active
- 1982-11-26 YU YU2655/82A patent/YU43727B/xx unknown
- 1982-11-26 CS CS828515A patent/CS238637B2/cs unknown
- 1982-11-29 ZW ZW252/82A patent/ZW25282A1/xx unknown
- 1982-11-30 PT PT75923A patent/PT75923B/pt unknown
- 1982-11-30 DD DD82245370A patent/DD206534A1/xx unknown
- 1982-11-30 DO DO1982004083A patent/DOP1982004083A/es unknown
- 1982-11-30 DK DK532682A patent/DK159797C/da not_active IP Right Cessation
- 1982-12-01 JO JO19821225A patent/JO1225B1/en active
- 1982-12-01 PL PL1982239301A patent/PL139503B1/pl unknown
- 1982-12-01 HU HU823858A patent/HU187802B/hu unknown
- 1982-12-01 NO NO824023A patent/NO159060C/no not_active IP Right Cessation
- 1982-12-01 MA MA19871A patent/MA19658A1/fr unknown
- 1982-12-01 BR BR8206982A patent/BR8206982A/pt not_active IP Right Cessation
- 1982-12-01 KR KR8205393A patent/KR880001206B1/ko not_active Expired
- 1982-12-01 EG EG710/82A patent/EG15502A/xx active
- 1982-12-01 SU SU823520359A patent/SU1514239A3/ru active
- 1982-12-01 ES ES517853A patent/ES8401720A1/es not_active Expired
- 1982-12-02 JP JP57212580A patent/JPS58113123A/ja active Granted
- 1982-12-02 MX MX19541182A patent/MX195411A/es unknown
-
1986
- 1986-01-28 KE KE3601BD patent/KE3601D/xx unknown
- 1986-03-20 HK HK195/86A patent/HK19586A/xx not_active IP Right Cessation
- 1986-04-08 US US06/850,430 patent/US4758598A/en not_active Expired - Fee Related
- 1986-12-30 MY MY502/86A patent/MY8600502A/xx unknown
-
1991
- 1991-02-11 SA SA91110229A patent/SA91110229B1/ar unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4758598A (en) | Solid shaped articles | |
| EP0084705B1 (en) | Process for preparing solid shaped articles | |
| CA1097233A (en) | Packages | |
| US5827541A (en) | Process for preparing solid pharmaceutical dosage forms of hydrophobic substances | |
| EP0404490B1 (en) | Fast dissolving dosage forms | |
| KR100194241B1 (ko) | 약제형 및 그 밖의 다른 복용형 | |
| GB2111423A (en) | Moulding quick-dissolving dosage units | |
| CA2023200A1 (en) | A new freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs | |
| EP0910345A1 (en) | Biconvex rapidly disintegrating dosage forms | |
| GB2138290A (en) | Divisible polyacrylate-based tablet | |
| EP0048194A2 (en) | Lyophilization process | |
| JPH04325156A (ja) | 凍結乾燥固形物の製造方法 | |
| GB2328154A (en) | A method of tabletting comprising forming a mixture, containing active agent & free-flowing ice particles, into a tablet & removing the ice from the tablet | |
| DD206534A5 (de) | Verfahren zur herstellung eines festen geformten gegenstandes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK9A | Patent expired |